Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hacker

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Cancers|January 21, 2022
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 VectorsNadja Meumann, Christian Schmithals, Leroy Elenschneider, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2021
Corrigendum to "Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'" [European Journal of Cancer 135 (2020) 1-7]C Benedikt Westphalen, Carsten Bokemeyer, Reinhard Büttner, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2020
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'Benedikt C Westphalen, Carsten Bokemeyer, Reinhard Büttner, et al.
Nature Communications|October 24, 2023
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trialMaria Pouyiourou, Bianca N Kraft, Timothy Wohlfromm, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Cancers|January 21, 2022
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 VectorsNadja Meumann, Christian Schmithals, Leroy Elenschneider, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2021
Corrigendum to "Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'" [European Journal of Cancer 135 (2020) 1-7]C Benedikt Westphalen, Carsten Bokemeyer, Reinhard Büttner, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2020
Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'Benedikt C Westphalen, Carsten Bokemeyer, Reinhard Büttner, et al.
Nature Communications|October 24, 2023
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trialMaria Pouyiourou, Bianca N Kraft, Timothy Wohlfromm, et al.
Pageof 7